|Bid||121.11 x 800|
|Ask||121.26 x 900|
|Day's range||120.72 - 122.64|
|52-week range||110.34 - 158.97|
|Beta (5Y monthly)||0.66|
|PE ratio (TTM)||31.99|
|Forward dividend & yield||1.52 (1.25%)|
|Ex-dividend date||03 Aug 2021|
|1y target est||N/A|
CRYSTAL LAKE, Ill., September 09, 2021--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, will host a virtual Capital Markets Day on Friday, September 10, 2021. The event will begin at 9:00 a.m. EDT. Senior executives from the company will speak and then answer questions from the audience. Interested parties can access the presentation slides and listen live by visiting the Investor Relations page at www.aptar.com.
CRYSTAL LAKE, Ill., September 07, 2021--AptarGroup, Inc. (NYSE: ATR) today announced with great sadness that Dr. Joanne Smith, a valued longtime member of the Board of Directors, has passed away.
CRYSTAL LAKE, III., September 02, 2021--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that following the signature of a share purchase agreement on July 22, 2021 and the approval of the French Ministry of Economy under the foreign investment clearance regulations, it has completed the acquisition of a majority stake in Voluntis (ENXTPA: ALVTX) from the company's reference shareholders and certain